The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 131.00
High: 133.00
Low: 131.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consent Solicitation Early Consent Deadline

6 Feb 2018 07:00

RNS Number : 9809D
Nationwide Building Society
06 February 2018
 

 

Nationwide Building Society

(incorporated in England under the Building Societies Act 1986, as amended)

update regarding the consent solicitation and proposal to all holders (the Noteholders) of its outstanding

€750,000,000 6.75 per cent. Subordinated Notes due 22 July 2020 (ISIN: XS0527239221) (the Notes)

6 February 2018. On 25 January 2018, Nationwide Building Society (the Society) announced an invitation (the Consent Solicitation) to holders of the Notes to consent to the modification of the terms and conditions of the Notes (the Conditions) and the Trust Deed constituting the Notes, as proposed by the Society (the Proposal) for approval by an extraordinary resolution (an Extraordinary Resolution) at a meeting of the Noteholders (the Meeting), all as further described in the Consent Solicitation Memorandum prepared by the Society dated 25 January 2018 (the Consent Solicitation Memorandum). Capitalised terms used and not otherwise defined in this announcement have the meaning given in the Consent Solicitation Memorandum.

The Early Consent Deadline for the Consent Solicitation was 4.00 p.m. (London time) on 5 February 2018. As at the Early Consent Deadline, Solicitation Instructions had been received in respect of 79.31 per cent. of the aggregate principal amount of the Notes outstanding, of which 99.62 per cent. are instructions in favour of the Extraordinary Resolution.

Accordingly, subject to any revocation of Solicitation Instructions in the limited circumstances in which revocation is permitted as described in the Consent Solicitation Memorandum, the Meeting of Noteholders convened for 10.00 a.m. (London time) on 20 February 2018 will be quorate and the Extraordinary Resolution will be passed.

The Society will announce the results of the Meeting as soon as reasonably practicable after the Meeting.

Further details on the transaction can be obtained from:

THE SOLICITATION AGENTS

BNP Paribas

10 Harewood Avenue

London NW1 6AA

United Kingdom

 

Telephone: +44 20 7595 8668

Attention: Liability Management Group

Email: liability.management@bnpparibas.com

UBS Limited5 BroadgateLondon EC2M 2QSUnited Kingdom

 

Telephone: +44 20 7568 2133

Attention: Liability Management Group

Email: ol-liabilitymanagement-eu@ubs.com

 

Requests for documentation and information in relation to the procedures for delivering Solicitation Instructions should be directed to:

TABULATION AGENT

Lucid Issuer Services Limited

Tankerton Works

12 Argyle Walk

London WC1H 8HA

United Kingdom

 

Telephone: +44 20 7704 0880

Attention: David Shilson / Arlind Bytyqi

Email: nationwide@lucid-is.com

Inside Information Notice

This announcement is released by Nationwide Building Society and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Alex Wall, Head of Capital, Ratings & Investor Relations of Nationwide Building Society.

DISCLAIMER: This announcement must be read in conjunction with the Consent Solicitation Memorandum. The Consent Solicitation Memorandum contains important information which should be read carefully before any decision is made with respect to the Consent Solicitation. If any Noteholder is in any doubt as to the action it should take or is unsure of the impact of the implementation of the Consent Solicitation or the Proposal, it is recommended to seek its own financial and legal advice, including in respect of any tax consequences, immediately from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee or intermediary must contact such entity if it wishes to participate in the Consent Solicitation or otherwise participate in the Proposal. None of the Society, the Solicitation Agents, the Tabulation Agent, the Trustee or the Principal Paying Agent makes any recommendation whether Noteholders should participate in the Consent Solicitation or otherwise participate in the Proposal.

Nothing in this announcement or the Consent Solicitation Memorandum constitutes or contemplates an offer of, an offer to purchase or the solicitation of an offer to purchase or sell any security in any jurisdiction. The distribution of this announcement and the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law, and persons into whose possession this announcement or the Consent Solicitation Memorandum comes are requested to inform themselves about, and to observe, any such restrictions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUUAPUPRGBA
Date   Source Headline
19th Jul 20162:41 pmRNSPublication of Final Terms
19th Jul 20162:40 pmRNSPublication of Final Terms
7th Jul 201611:06 amRNSDoc re. Appointment of Senior Independent Director
23rd Jun 20161:38 pmRNSPublication of a Prospectus
21st Jun 20162:55 pmRNSNotice of Results of Covered Bondholder Meeting
7th Jun 20169:59 amRNSPost Stab Notice - Nationwide EUR1.25Bn .5% Oct 19
31st May 201611:17 amRNSPost Stab Notice - Nationwide EUR1.25Bn .5% Oct 19
31st May 201610:22 amRNSPost Stabilisation Notice
26th May 20169:39 amRNSAnnouncement of a Consent Solicitation
24th May 20161:25 pmRNSPublication of Suppl.Prospcts
24th May 20167:00 amRNSPreliminary Results Announcement
23rd May 20167:00 amRNSDirectorate Change
6th May 20165:05 pmRNSPublication of Final Terms
6th May 20169:33 amRNSPost-Stabilisation Notice - Nationwide
5th May 20163:21 pmRNSPublication of Final Terms
4th May 20166:20 pmRNSPublication of Final Terms
3rd May 20163:14 pmRNSPublication of Final Terms
28th Apr 20169:24 amRNSPre Stabilisation Notice
27th Apr 20163:03 pmRNSPublication of Final Terms
27th Apr 20162:56 pmRNSPublication of Final Terms
22nd Apr 201612:00 pmRNSPublication of Final Terms
20th Apr 20165:41 pmRNSPublication of Final Terms
19th Apr 201612:50 pmRNSPublication of Amended Final Terms
18th Apr 201611:54 amRNSPublication of Final Terms
15th Apr 201611:50 amRNSPublication of Final Terms
12th Apr 201612:33 pmRNSCCDS - Notification of adjustment to PIR cap
11th Apr 20165:39 pmRNSPublication of Final Terms
11th Apr 201610:59 amRNSPublication of Final Terms
24th Mar 201610:57 amRNSPublication of Final Terms
24th Mar 201610:54 amRNSPublication of Final Terms
21st Mar 20164:20 pmRNSPublication of Final Terms
18th Mar 201611:19 amRNSPublication of Final Terms
18th Mar 201611:19 amRNSPublication of Final Terms
18th Mar 201611:14 amRNSPublication of Final Terms
3rd Mar 201612:40 pmRNSPublication of Final Terms
3rd Mar 201612:33 pmRNSPublication of Final Terms
26th Feb 20165:13 pmRNSPublication of Final Terms
26th Feb 20165:07 pmRNSPublication of Final Terms
26th Feb 20165:07 pmRNSPublication of Final Terms
23rd Feb 20166:14 pmRNSPublication of Final Terms
23rd Feb 20167:00 amRNSPublication of Final Terms
18th Feb 201612:31 pmRNSPublication of Final Terms
17th Feb 20165:10 pmRNSPublication of Final Terms
12th Feb 20162:54 pmRNSPublication of Supplement - Replacement
12th Feb 20162:42 pmRNSPublication of Supplement
12th Feb 20167:00 amRNSInterim Management Statement
2nd Feb 201610:00 amRNSJOE GARNER TO JOIN AS CEO ON 5 APRIL 2016
28th Jan 20165:33 pmRNSPublication of Final Terms
28th Jan 20165:25 pmRNSPublication of Final Terms
27th Jan 201612:59 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.